 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | Ministry of health- Department of epidemiology and disease control |
| Street 1: | 71, Avenue Ibn Sina, Agdal |
| Street 2: | |
| City: | Rabat |
| Province: | |
| Post Code: | |
| Country: | Morocco |
| Phone: | 00212537671271 |
| Organization Email: | delmdirection@gmail.com |
| Web Site: | http://www.sante.gov.ma |
| Other Online Presence: | |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | Countries |
| Is your organization legally registered in your country: | Yes |
| If yes, please enter your registration number: | |
| Organization Type - Primary: | Governmental Organization |
| Organization Type - Secondary: | None |
| Organization Description: | |
| 1-Some missions and main focus of work: a-designing and carrying out diseases control programs b-ensuring epidemiological surveillance of diseases c-performing epidemiological investigations and studies 2-We are managing the national anti-tuberculosis programme as the service of respiratory diseases in the ministry of health. 3-Our national strategic plan 2018-2021 to fight tuberculosis in Morocco intends to reduce by 40% deaths due to tuberculosis in 2021. We are acting in accordance with WHO vision and pursuing sustainable development goals to eliminate tuberculosis in Morocco by 2030 |
|
| Do you know about the UNHLM declaration: | |
Specializations / Areas of Work | |
|
Advocacy Civil Society and Community Engagement Delivery of health services and care Engaging political leaders and ensuring inclusive leadership Funding, including innovative and optimized approach to funding TB Care Provision of drugs, diagnostics and commodities Research and Development Technical Assistance Working on Community, Rights and Gender (CRG) Working on Key Populations related to TB |
Other Organization Information | |
| Total number of staff in your organization: | 51 - 99 |
| Number of full-time staff who are directly involved with TB: | 6 - 10 |
| Number of part-time staff who are directly involved with TB: | 0 |
| Number of volunteers who are directly involved with TB: | 0 |
| How did you hear about the Stop TB Partnership: | Stop TB communications |
| If you were informed or referred by another partner of the Stop TB Partnership please tell us who: | |
| Why do you wish join the Stop TB Partnership: | Resource mobilization |
| Are you a member of a Stop TB national partnership: | Morocco |
| Are you in contact with your national TB programme: | Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| the service of respiratory diseases in the ministry of health is the entity responsible for the design,the monitoring and the evaluation of the national anti-tuberculosis programme.The service also leads and manages the programme's implementation and coordinate the outlined activities. | |
Geographical Reach | |
| Which country is your headquarters located in: | Morocco |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
Morocco |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
TB Care Delivery: The goal of the current national strategic plan (NSP), which covers the timeframe from July 2017 to December 2021, is to reduce the number of TB deaths by 40% in 2021 compared to 2015 and, to this end, operational objectives were established. Indeed, this NSP aims at increasing more TB case detection and treatment success rate, especially in highly urbanized regions, through the improvement and strengthening of the existing NTP services, the involvement of all care providers and the reinforcement of TB services for high risk groups and vulnerable populations. We are aiming for the detection of 92% of TB cases in 2021(83% in 2015)and targetting more than 90% of therapeutic success in 2021 (86% in 2015). Drug-Resistant TB: the NSP develops and implements the programmatic management of drug-resistant TB.We are aiming for the detection of at least 75% of multi-drug-resistant TB cases in 2021 and targetting more than 80% of therapeutic success in 2021. TB-HIV: in order to still reduce the number of TB deaths, the NSP also aims at improving and strengthening TB/HIV joint activities. We are aiming to test, for HIV, 95% of TB patients and to place 100% of HIV-positive TB patients on antiretroviral drugs according to international guidelines by the end of 2021. Laboratory Strengthening: The NSP is aiming to increase access to quality-assured AFB microscopy, to improve the diagnosis of TB among AFB smear-negative TB cases and to increase access to rapid laboratory diagnosis of drug-resistant TB among TB patients considered at risk of M/XDR-TB. It also establishes laboratory quality management system New Diagnostics: The NSP introduces the new molecular biology techniques for the diagnosis and treatment of TB and M/XDR-TB in combination of digital radiology: Xpert MTB/RIF, Hain... The NSP also recommends the LED microscopy technique. New TB Drugs: The NSP wants to ensure the adoption of new TB drugs and regimens at the country leve, like short regimens for MDR TB, according to international guidelines Fundamental Research: The NSP targets the characterization of human TB using modern biomedical, epidemiological and clinical approaches, especially for MDR and XDR TB. It also aims to understand the natural history of M. tuberculosis infection in extrapulmonary TB. Research: The NSP also includes a technical assistance plan which specifies the expertise needed to implement certain interventions and activities, needed to increase early TB case-detection and improve the diagnosis of drug-sensitive and -resistant TB, and TB/HIV co-infection. |
|
Declaration | |
| Declaration of interests: No conflicts of interest were delacred. | |
| Application date: | September 29, 2017 |
| Last updated: | October 30, 2017 |